Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Inhaled nitric oxide in preterm babies with respiratory failure or ventilator dependence
will:
1. decrease the incidence of Bronchopulmonary Dysplasia (BPD) or death
2. shorten the length of oxygen therapy and hospital stay ,reduce the cost of hospital stay
without increasing adverse effect
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Fudan University
Collaborators:
Children's Hospital of Fudan University Children's Hospital of Hebei Province Hunan Children's Hospital QuanZhou Women and Children's Hospital Shen-Zhen City Maternity and Child Healthcare Hospital The First Affiliated Hospital of Xiamen University Xiamen Women's and Children's Hospital